Scot is co-chair of Reed Smith’s global Life Sciences Health Industry Group and a trusted advisor to leading health care companies and investors. He brings decades of experience navigating complex regulatory frameworks, defending high-stakes government investigations and litigation, and structuring sophisticated transactions and innovative business arrangements across the health care ecosystem. Clients rely on his pragmatic judgment, strategic advocacy, and business-minded problem solving in matters where legal risk, operational demands, and market realities intersect.
Based in Washington, D.C., Scot’s practice centers on federal and state health care regulatory and policy issues. He has deep experience with False Claims Act defense, internal and government investigations, and compliance with the Anti-Kickback Statute, the physician self-referral (Stark) law, and related state laws. He has negotiated numerous government settlements and corporate integrity agreements, including some of the most significant resolutions in recent decades.
Scot counsels a broad spectrum of health care stakeholders, including post-acute providers, large retail pharmacies, manufacturers, managed care organizations, digital health companies, outpatient rehabilitation providers, optometry and dental platforms, and investors – particularly private equity. He also advises on regulatory due diligence for mergers and acquisitions and other transactions, helping clients evaluate and mitigate risk while advancing strategic objectives.
Qualifikationen
Auszeichnungen
- Ranked in Chambers USA for District of Columbia Healthcare (2022-2025)
- Named a Notable Practitioner, Chambers USA – Healthcare (2021)
- Named a Life Sciences Star for Regulatory in the LMG Life Sciences Guide (2015-2021) and a Life Sciences Star for Healthcare Pricing & Reimbursement in the LMG Life Sciences Guide (2022-2025)
- Cited by The Legal 500 US in its firm write-up for the Industry Focus – Healthcare: Service Providers category (2013-2021)
- Listed on Nightingale’s list of Outstanding Young Healthcare Lawyers (2006)
Notable Quotes
- 4 March 2025 “HHS Cuts Hit Attys Tackling Medicare Appeals Backlog” Law360
- 18 August 2023 “In A Post-Dobbs World, Pharmacists Still Face Uncertainty” DrugTopics
- 11 May 2023 “The COVID-19 public health emergency is ending. Here’s what’s changing.” Modern Healthcare
- 24 June 2022 “Reed Smith Prepares to Guide Clients on Post-Roe’ Contingencies” Law.com
- 11 February 2022 “Health Hires: Reed Smith, McGuireWoods” Law360
- 29 May 2018 “Revolving Doors: City laterals pick up pace as Baker McKenzie and DWF make moves while Reed Smith expands in the US” Legal Business UK
- 24 May 2018 “Reed Smith raids Norton Rose for life sciences/healthcare team, adding Austin office” Law.com
- 29 June 2016 “The 9 Firms GCs Love For Health Care Work” Law360
- 12 February 2016 “CMS Clarifies How to Report Medicare Overpayments” Family Practice News
- 12 February 2016 “Are Providers Happy With The 60-DAY Final Rule?” Bloomberg BNA Health Law Report
- 24 December 2015 “Health Care Regulation To Watch In 2016” Law360
- May 2012 “Fraud Fighters Mine Data: Auditors Pave New Path With Aggressive Investigative Tactics” Provider Magazine
- 18 May 2010 “Healthcare Compliance Within the Healthcare Sector” Compliance Week
- 1 August 2009 “Watch Out For New False Claims Rules” Eli’s Rehab Report, Vol. 18, No. 8
- 17 June 2009 “President’s Health Care Reform Package Adds $1 Billion in Medicare Fraud Savings” The Bureau of National Affairs, Inc., Health Care Fraud Report
- 1 June 2009 “New Law Tightens Scope of False Claims Act: What looked like a law that cracks down on mortgage and financial fraud could pack a punch for your practice” Part B Insider, Vol. 10, No. 19
- 22 December 2006 “Bristol Says U.S. Inquiry Is Settled” The New York Times